Obstructive sleep apnoea, glucose tolerance and liver steatosis in obese women

Journal of International Medical Research

Volumn 35, Issue 4, 2007, Pages 458-466

  Acarturk G ^a   Unlu M ^a   Yuksel S ^a   Albayrak, R ^a   Koken T ^a   Peker, Y ^b  

^a Afyon Kocatepe Universitesi Rektorluk Ahmet Necdet Sezer Arastirma ve Uygulama Hastanesi   (Turkey)

^b SKARABORG HOSPITAL   (Sweden)

Author keywords

Hypertension; Impaired glucose tolerance; Liver steatosis; Obesity; Sleep apnoea

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE;

ABDOMINAL RADIOGRAPHY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FATTY LIVER; FEMALE; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POLYSOMNOGRAPHY; SLEEP APNEA SYNDROME; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 34547877539     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000703500404     Document Type: Article

References (37)

1. Skarfors ET, Selinus KI, Lithell HO: Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. BMJ 1991; 303: 755-760.
2. Harris MI, Hadden WC, Knowler WC, et al: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 24 - 74 yr. Diabetes 1987; 36: 523-534.
3. Blake DR, Meigs JB, Muller DC, et al: Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes 2004; 53: 2095-2100.
4. Vermeer SE, Sandee W, Algra A, et al for the Dutch TIA Trial Study Group: Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke. Stroke 2006; 37: 1413-1417.
5. Saydah SH, Loria CM, Eberhardt MS, et al: Subclinical states of glucose intolerance and risk of death in the US. Diabetes Care 2001; 24: 447-453.
6. Andersen T, Christoffersen P, Gluud C: The liver in consecutive patients with morbid obesity: a clinical, morphological, and biochemical study. Int J Obes 1984; 8: 107-115.
7. Angulo P: Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
8. Teli MR, James OF, Burt AD, et al: The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995; 22: 1714-1719.
9. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
10. Gupte P, Amarapurkar D, Agal S, et al: Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004; 19: 854-858.
11. Gami AS, Caples SM, Somers VK: Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am 2003; 32: 869-894.
12. Punjabi NM, Ahmed MM, Polotsky VY, et al: Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 2003; 136: 167-178.
13. Peker Y, Hedner J, Norum J, et al: Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002; 166: 159-165.
14. Zanchetti A, Chalmers JP, Arakawa K, et al: The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press 1993; 2: 86-100.
15. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus - provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
16. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28: S37-S42.
17. Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
19. Scatarige JC, Scott WW, Donovan PJ, et al: Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation. J Ultrasound Med 1984; 3: 9-14.
20. Rechtschaffen A, Kales A: A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages in Human Subjects. Los Angeles: Brain Information Service, UCLA, 1968.
21. Lavie P, Herer P, Hoffstein V: Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320: 479-482.
22. Tiihonen M, Partinen M, Narvanen S: The severity of obstructive sleep apnoea is associated with insulin resistance. J Sleep Res 1993; 2: 56-61.
23. Vgontzas AN, Papanicolaou DA, Bixler EO, et al: Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000; 85: 1151-1158.
24. Brooks B, Cistulli PA, Borkman M, et al: Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994; 79: 1681-1685.
25. Strohl KP, Novak RD, Singer W, et al: Insulin levels, blood pressure and sleep apnea. Sleep 1994; 17: 614-618.
26. Punjabi NM, Sorkin JD, Katzel LI, et al: Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002; 165: 677-682.
27. Meslier N, Gagnadoux F, Giraud P, et al: Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 2003; 22: 156-160.
28. Somers VK, Dyken ME, Clary MP, et al: Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-1904.
29. Assy N, Kaita K, Mymin D, et al: Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 2000; 45: 1929-1934.
30. Donati G, Stagni B, Piscaglia F, et al: Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut 2004; 53: 1020-1023.
31. Clark JM: The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006; 40(suppl 1): S5-10.
32. Chin K, Nakamura T, Takahashi K, et al: Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am J Med 2003; 114: 370-376.
33. Tanne F, Gagnadoux F, Chazouilleres O, et al: Chronic liver injury during obstructive sleep apnea. Hepatology 2005; 41: 1290-1296.
34. Joseph AE, Saverymuttu SH, al-Sam S, et al: Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991; 43: 26-31.
35. Mendler MH, Bouillet P, Le Sidaner A, et al: Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. J Hepatol 1998; 28: 785-794.
36. Graif M, Yanuka M, Baraz M, et al: Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol 2000; 35: 319-324.
37. Piccinino F, Sagnelli E, Pasquale G, et al: Complications following percutaneous liver biopsy. A multicentre retrospective study on 68 276 biopsies. J Hepatol 1986; 2: 165-173.